ResMed Inc. Officer & Director Michael J. Farrell Files Form 144 for $1.13M Proposed Sale
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice of Proposed Sale Company: RESMED INC (RMD) Insider: Farrell Michael J. (Officer, Director) Shares to Sell: 4,991 Common shares Approx. Value: $1,129,064.02 (~$226.22/share) Acquisition: Stock Option Exercise (Cash payment, 09/08/2026) Plan Adoption: 10/31/2024 (Rule 10b5-1) Broker: Fidelity Brokerage Services LLC
Comprehensive Analysis
Form 144 Analysis: ResMed Inc. (NYSE: RMD)
Summary
Officer and Director Michael J. Farrell filed a Form 144 notice on September 8, 2026, for the proposed sale of 4,991 shares of ResMed Inc. common stock, valued at approximately $1,129,064.02 (~$226.22 per share).
Key Details
- Securities to be Sold: 4,991 Common shares.
- Aggregate Market Value: $1,129,064.02.
- Origin of Shares: Acquired on September 8, 2026, via cash exercise of stock options from the issuer.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on October 31, 2024.
- Historical Activity (Past 3 Months):
- August 7, 2026: 4,991 shares sold for $1,026,596.29
- July 7, 2026: 4,991 shares sold for $1,090,770.57
- June 8, 2026: 4,991 shares sold for $968,064.34
Significance Assessment
- Trading Significance: Low
- Context: The transaction represents a routine, pre-scheduled monthly option exercise and sale program under a long-standing Rule 10b5-1 plan established in October 2024. The 4,991 shares represent a negligible fraction of ResMed's 144,252,306 outstanding shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.